Dystonia

Neurology: Clinical Practice

Volumn 5, Issue 3, 2015, Pages 232-240

  Berman, Brian D ^a   Jinnah, H A ^b,c  

^a Department of Neurology ^*  (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ANOCTAMIN 3; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CIP1 INTERACTING ZINC FINGER PROTEIN 1; GUANINE NUCLEOTIDE BINDING PROTEIN; THANATOS ASSOCIATED PROTEIN DOMAIN CONTAINING APOPTOSIS ASSOCIATED PROTEIN 1; TORSIN A; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN;

ANXIETY DISORDER; ARTICLE; BASAL GANGLION; BODY DISTRIBUTION; CLINICAL FEATURE; COGNITIVE DEFECT; CONSENSUS; DEPRESSION; DYSTONIA; FATIGUE; GENE MUTATION; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; MENTAL DISEASE; MOOD DISORDER; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; PAIN; PRIORITY JOURNAL; QUALITY OF LIFE; SLEEP DISORDER;

EID: 84930722902     PISSN: 21630402     EISSN: 21630933     Source Type: Journal    
DOI: 10.1212/CPJ.0000000000000128     Document Type: Article

References (21)

1. Albanese A, Bhatia K, Bressman S, et al. Phenomenology and classification of dystonia: a consensus update. Mov Disord 2013;28:863-873.
2. Kuyper DJ, Parra V, Aerts S, Okun MS, Kluger BM. Nonmotor manifestations of dystonia: a systematic review. Mov Disord 2011;26:1206-1217.
3. Stamelou M, Edwards M, Hallett M, Bhatia K. The non-motor syndrome of primary dystonia: clinical and pathophysiological implications. Brain 2012;135:1668-1681.
4. Paus S, Gross J, Moll-Müller M, et al. Impaired sleep quality and restless legs syndrome in idiopathic focal dystonia: a controlled study. J Neurol 2011;258:1835-1840.
5. Fabbrini G, Berardelli I, Moretti G, et al. Psychiatric disorders in adult-onset focal dystonia: a casecontrol study. Mov Disord 2010;25:459-465.
6. Gündel H, Wolf A, Xidara V, Busch R, Ceballos-Baumann A. Social phobia in spasmodic torticollis. J Neurol Neurosurg Psychiatry 2001;71:499-504.
7. Saunders-Pullman R, Shriberg J, Heiman G, et al. Myoclonus dystonia: possible association with obsessive-compulsive disorder and alcohol dependence. Neurology 2002;58:242-245.
8. Ozelius L, Hewett J, Page C, et al. The early-onset torsion dystonia gene (DYT1) encodes an ATPbinding protein. Nat Genet 1997;17:40-48.
9. Fuchs T, Gavarini S, Saunders-Pullman R, et al. Mutations in the THAP1 gene are responsible for DYT6 primary torsion dystonia. Nat Genet 2009;41:286-288.
10. Xiao J, Uitti R, Zhao Y, et al. Mutations in CIZ1 cause adult onset primary cervical dystonia. Ann Neurol 2012;71:458-469.
11. Charlesworth G, Plagnol V, Holmström K, et al. Mutations in ANO3 cause dominant craniocervical dystonia: ion channel implicated in pathogenesis. Am J Hum Genet 2012;91:1041-1050.
12. Kumar K, Lohmann K, Masuho I, et al. Mutations in GNAL: a novel cause of craniocervical dystonia. JAMA Neurol 2014;71:490-494.
13. Ledoux M, Dauer W, Warner T. Emerging common molecular pathways for primary dystonia. Mov Disord 2013;28:968-981.
14. Lehéricy S, Tijssen M, Vidailhet M, Kaji R, Meunier S. The anatomical basis of dystonia: current view using neuroimaging. Mov Disord 2013;28:944-957.
15. Prudente C, Hess E, Jinnah H. Dystonia as a network disorder: what is the role of the cerebellum? Neuroscience 2014;260:23-35.
16. Neychev VK, Gross RE, Lehericy S, Hess EJ, Jinnah HA. The functional neuroanatomy of dystonia. Neurobiol Dis 2011;42:185-201.
17. Zoons E, Booij J, Nederveen A, Dijk J, Tijssen M. Structural, functional and molecular imaging of the brain in primary focal dystonia-a review. Neuroimage 2011;56:1011-1020.
18. Malone A, Manto M, Hass C. Dissecting the links between cerebellum and dystonia. Cerebellum 2014;13:666-668.
19. Jankovic J. Medical treatment of dystonia. Mov Disord 2013;28:1001-1012.
20. Ramirez-Castaneda J, Jankovic J. Long-term efficacy and safety of botulinum toxin injections in dystonia. Toxins (Basel) 2013;5:249-266.
21. Truong D. Botulinum toxins in the treatment of primary focal dystonias. J Neurol Sci 2012;316: 9-14.